Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Applied DNA Sciences Inc (APDN)
:APDN
Holding APDN?
Track your performance easily
APDN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.12 - $14.40
Previous CloseN/A
Volume2.49M
Average Volume (3M)7.60M
Market Cap
$10.49M
Enterprise Value$826.63K
Total Cash (Recent Filing)$2.96M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.45
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.89
Shares Outstanding55,188,522
10 Day Avg. Volume3,559,319
30 Day Avg. Volume7,604,791
Standard Deviation0.77
R-Squared0.00069
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.90
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.08
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit0.81
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Applied DNA Sciences News
PremiumCompany Announcements
Applied DNA Sciences Advances in Genetic Medicines Market
PremiumCompany Announcements
Applied DNA Sciences Announces Leadership Changes and RestructuringPremiumPre-Earnings
Is APDN a Buy, Before Earnings?
PremiumCompany Announcements
Applied DNA Sciences Announces $6.5 Million Fundraising PlanOwnership Overview
1.00%
Insiders
0.03% Mutual Funds
<0.01% Other Institutional Investors
98.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
APDN FAQ
What was Applied DNA Sciences Inc’s price range in the past 12 months?
Applied DNA Sciences Inc lowest stock price was $0.12 and its highest was $14.40 in the past 12 months.
What is Applied DNA Sciences Inc’s market cap?
Applied DNA Sciences Inc’s market cap is $10.49M.
When is Applied DNA Sciences Inc’s upcoming earnings report date?
Applied DNA Sciences Inc’s upcoming earnings report date is Feb 13, 2025 which is in 26 days.
How were Applied DNA Sciences Inc’s earnings last quarter?
Applied DNA Sciences Inc released its earnings results on Dec 17, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.34 by $0.02.
Is Applied DNA Sciences Inc overvalued?
According to Wall Street analysts Applied DNA Sciences Inc’s price is currently Overvalued.
Does Applied DNA Sciences Inc pay dividends?
Applied DNA Sciences Inc does not currently pay dividends.
What is Applied DNA Sciences Inc’s EPS estimate?
Applied DNA Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Applied DNA Sciences Inc have?
Applied DNA Sciences Inc has 55,188,522 shares outstanding.
What happened to Applied DNA Sciences Inc’s price movement after its last earnings report?
Applied DNA Sciences Inc reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.34. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Applied DNA Sciences Inc?
Currently, no hedge funds are holding shares in APDN
---
Company Description
Applied DNA Sciences Inc
Applied DNA Sciences, Inc. engages in the provision of security solutions. It offers molecular-based technology solutions and services that can help protect products, brands, supply chains, and intellectual property of companies, governments, and consumers from theft, counterfeiting, fraud, and diversion. Its products include the following brands: Applied DNA Sciences, SigNature, molecular tags, SigNature, T molecular tags, fiberTyping, DNAnet, digitalDNA, SigNify, BackTrac, Beacon, and CertainT. The company was founded in 1983 and is headquartered in Stony Brook, NY.
---
APDN Company Deck
---
APDN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with significant revenue decline and increased cash burn, alongside strategic advancements such as a new commercial agreement and the launch of a pharmacogenomic testing service. The company's progress towards GMP certification and a strengthened balance sheet are positive, but financial challenges, including Nasdaq compliance, remain pressing.Read More>---
APDN Stock 12 Month Forecast
Average Price Target
―Technical Analysis
NAYA Biosciences
―
Sonoma Pharmaceuticals
―
Aethlon Medical
―
T2 Biosystems
―
Cyclacel Pharmaceuticals
―
Novavax
―
Best Analysts Covering APDN
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-72.86%
reiterated a buy rating 7 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -72.86% per trade.
---